In GC, a reduced or null E-cadherin expression has been correlated with infiltrative capacity and metastasis; in this type of cancer, the most commonly reported anomalies in E-cadherin are germline and somatic mutations, and somatic loss of heterozygosity (LOH) and promoter methylation [6]. This evidence concerns the gene CDH1 and cancer.